取决于差异化的EBF1活性决定了CD22转录和白血病对伊诺图祖马布臭加米辛的敏感性
Carolin S Escherich1,2, Zhenhua Li1, Kelly R Barnett1
1Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN.
Blood
|May 28, 2025
概括
早期B细胞因子1 (EBF1) 调节CD22表达,影响B细胞急性淋巴细胞白血病 (B-ALL) 中的伊诺图祖马布臭加米辛 (InO) 敏感性. 了解这种联系可以改善白血病治疗反应.
科学领域:
- 血液学 血液学 血液学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 伊诺图祖马布奥佐加米辛 (InO) 是一种有效的抗体-药物联合剂,用于向CD22的淋巴细胞恶性瘤.
- 在B细胞急性淋巴细胞白血病 (B-ALL) 中,CD22的表达有所不同,这影响了InO的敏感性.
- 控制CD22表达和B-ALL对INO反应的因素尚未完全理解.
研究的目的:
- 研究B-ALL.中CD22表达变异的基础分子机制.
- 确定CD22表达的关键调节者及其对InO敏感性的影响.
- 探索这些调节剂在B-ALL亚型中治疗耐药性的作用.
主要方法:
- 196个人类B-ALL样本的多原子特性.
- 对INO的ex vivo敏感性概况.
- 转录因子选,ATAC-seq和CRISPR干扰测试. 这些测试包括:
主要成果:
- 在前-pro-B阶段的白血病分化停止与INO抗性相关.
- 早期B细胞因子1 (EBF1) 被确定为CD22表达的关键调节者.
- 在INO敏感B-ALL的开放色素区域中,EBF1结合丰富;EBF1的破坏增加了INO的抗性.
- 在BCR::ABL1 ALL中EBF1下调/变化导致CD22和INO电阻降低.
结论:
- 在B细胞发育过程中,EBF1直接影响CD22的表达.
- 在CD22调节中EBF1的作用有助于因诺反应的患者间变异性.
- 这些发现提供了对B-ALL.治疗耐药性机制的见解.
相关概念视频
Lineage Commitment
3.2K
Commitment is the process whereby stem cells:
3.2K
Differentiation of Common Myeloid Progenitor Cells
3.3K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.3K
B Cell Activation and Differentiation
6.9K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
6.9K
T Cell Activation and Clonal Selection
5.9K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
5.9K


